Chemical Structure : AP-7-168
CAS No.: 2816062-15-2
Catalog No.: PC-27918Not For Human Use, Lab Use Only.
AP-7-168 is a specific β-arrestin-biased negative allosteric modulator (NAM) of β2-adrenergic receptor (β2AR), mediates β2AR dimerization with pEC50 of 5.93 in HEK cells, is >1,000-fold effective at inhibiting β-arrestin2 recruitment versus cAMP production.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $118 | In stock | |
| 10 mg | $178 | In stock | |
| 25 mg | $298 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AP-7-168 is a specific β-arrestin-biased negative allosteric modulator (NAM) of β2-adrenergic receptor (β2AR), mediates β2AR dimerization with pEC50 of 5.93 in HEK cells, is >1,000-fold effective at inhibiting β-arrestin2 recruitment versus cAMP production.
AP-7-168 shows direct binding to the monomeric β2AR receptor with Kd of 30 uM.
AP-7-168 promotes β2AR dimerization in continuous membranes and in cells.
AP-7-168 (10 uM) caused a slight reduction in the monomer–Gs binding affinity (KD = 1.7 μM) in BLI assays.
AP-7-168 biases TM6 conformational dynamics of β2AR in both dimer and monomer.
AP-7-168-bound β AR dimers inhibits GRK5-mediated phosphorylation of β2AR in both detergent and nanodiscs.
| M.Wt | 433.30 | |
| Formula | C20H19BrF2N4 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
6-Bromo-N4-cyclohexyl-N2-(3,4-difluorophenyl)-2,4-quinazolinediamine |
|
1. Shen J, et al. Nature. 2026 Aug 19. doi: 10.1038/s41586-026-10892-y.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright